Cargando…
Cancer Treatment Response to Checkpoint Inhibitors Is Associated with Cytomegalovirus Infection
Programmed cell death protein-1 (PD-1) and programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors induce tumor response by activating the patient’s own immune system to fight cancer. Tumors with high tumor mutational burden or those that express high levels of PD-1/PD-L1 are more responsive to...
Autores principales: | Villanueva, Faith, Yuan, Cai, Drane, Walter, Dang, Long, Nguyen, Thu-Cuc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026877/ https://www.ncbi.nlm.nih.gov/pubmed/32104613 http://dx.doi.org/10.7759/cureus.6670 |
Ejemplares similares
-
Cancer Genes Mutations in Benign Metastasizing Leiomyoma: A Case Report
por: Nguyen, Thu-Cuc, et al.
Publicado: (2019) -
Severe Immune-Mediated Colitis Induced by Checkpoint Inhibitors in an Adolescent With Lynch Syndrome
por: Lee, Rachel V, et al.
Publicado: (2023) -
Diagnosis of Congenital Cytomegalovirus (cCMV) in an Asymptomatic Neonate on Placental Pathology
por: Boddu, Praveen Kumar, et al.
Publicado: (2022) -
Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment
por: Wang, Aoyun, et al.
Publicado: (2022) -
Cytomegalovirus and Epstein-Barr Virus Co-infection in a Patient With Chronic Granulomatous Disease Co-existing With Familial Mediterranean Fever and Early-Onset Inflammatory Bowel Disease: A Case Report
por: Al Zu’bi, Yazan O, et al.
Publicado: (2023)